Personas / Equipo Humano

Andrés Nascimento Osorio

Buscador de publicaciones

Publicaciones

  • Gómez-Andrés D, Munell F, Pascual Pascual SI, Vázquez López M, Cols M, García Campos O, Garrido C, Antonia Grimalt M, Hernandez A, Madruga-Garrido M, Medina J, Molera C, Moreno T, Muñoz Cabello B, Nascimento-Osorio A, Pinillos-Pisón S and Ortez-Gonzalez CI.

    Multidisciplinary management of X-linked myotubular myopathy in Spain and Portugal: A case series analysis.

    Neurologia . 41(4): 501935-501935.

    [doi:10.1016/j.nrleng.2026.501935]

  • Cicala, G, Capasso, A, Villa, M, Coratti, G, Arpaia, C, Agosto, C, Corti, S, Ricci, F, Bruno, C, Matesanz, S, Gross, B, Mendoza, DG, Kuntz, N, Kirschner, J, Ziegler, A, Servais, L, Asselman, FL, van der Pol, L, Castiglioni, C, Nascimento-Osorio A, Tizzano E, Mendonça, RH, Zanoteli, E, Munot, P, Scoto, M, Finkel, R, Pane, M, Tiziano, FD and Mercuri, E.

    The phenotypic spectrum and genetic determinants of severe spinal muscular atrophy in individuals with a single SMN2 copy: an international retrospective observational study

    EClinicalMedicine . 95: . Nº de citas: 1

    [doi:10.1016/j.eclinm.2026.103931]

  • Gómez-Andrés, D, Munell, F, Pascual, SIP, López, MV, Cols M, Campos, OG, Garrido, C, Grimalt, MA, Hernandez, A, Madruga-Garrido, M, Medina J, Molera C, Moreno, T, Cabello, BM, Nascimento-Osorio A, Pinillos-Pisón S and Ortez-Gonzalez CI.

    Multidisciplinary management of X-linked myotubular myopathy in Spain and Portugal: A case series analysis

    NEUROLOGIA . 41(4): .

    [doi:10.1016/j.nrl.2025.501935]

  • Tachó-Piñot R, Bashour H, Filipska M, Corral-Vazquez C, Guzman M, Marcos-Fa X, Martinuzzi D, Honner H, Canales Herrerias P, Tejedor Vaquero S, Sáez Gordón A, Perera-Bel J, Domínguez Barragán J, Arcos-Ribas B, de Campos-Mata L, Slabodkin A, Chernigovskaya M, Rodríguez de la Concepción ML, Gutierrez-Marcos J, García-García AP, Nascimento-Osorio A, Pascal M, Yagüe-Ribes J, Juan-Otero M, Arostegui-Gorospe JI, Hijano Esqué R, Sánchez Font A, Ehl S, Grimbacher B, Rizzi M, Dotta L, Chen K, Badolato R, Alsina L, Mehandru S, Cunningham-Rundles C, Carrillo J, Magri G, Greiff V and Cerutti A.

    IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens

    JOURNAL OF EXPERIMENTAL MEDICINE . 223(5): . Nº de citas: 4

    [doi:10.1084/jem.20251752]

  • Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento-Osorio A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Furgerson M, Ding K, Singh P, Potter R, Asher DR, Murphy AP, Reid C, Hooper G, Torre CO, Manfrini M and Rodino-Klapac LR.

    Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial

    Neurology and Therapy . 15(2): 545-559. Nº de citas: 6

    [doi:10.1007/s40120-025-00879-8]

  • Zwingli G, Putananickal N, Schmidt S, Nagy S, Rubino-Nacht D, Schaedelin S, Amthor H, Childs AM, Deconinck N, Horrocks I, Houwen-van Opstal S, Laugel V, Lopez Lobato M, Nascimento-Osorio A, Schara-Schmidt U, Spinty S, von Moers A, Lawrence F, Hafner P, Dorchies OM, Fischer D and Henzi BC.

    Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial

    NEUROMUSCULAR DISORDERS . 61: 106366-106366.

    [doi:10.1016/j.nmd.2026.106366]

  • Domínguez-González C, Barba Romero MÁ, Caballero Eraso C, de Las Heras J, Farrero Muñoz E, García-Campos Ó, González M, Grau JM, Hernández-Voth A, Juntas Morales R, León Hernández JC, Ley Martos M, López-Padilla D, Muelas N, Nascimento-Osorio A, Olivé M, Paradas C, Pardo Fernández J, Pascual SI, Pitarch I, Sancho J and Díaz-Manera J.

    Recommendations for the diagnosis, treatment, and follow-up of late-onset Pompe disease.

    Neurologia . 41(2): 501933-501933. Nº de citas: 1

    [doi:10.1016/j.nrleng.2025.501933]

  • Muntoni, F, Nascimento-Osorio A, Shin, J, Guglieri, M, Stettner, GM, Veerapandiyan, A, Gallo, S, Shi, HL, Gundapaneni, B, Neelakantan, S, Lobello, K, Shen, Q, Levy, D and Mercuri, E.

    Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised placebo-controlled study

    LANCET NEUROLOGY . 25(3): 245-255. Nº de citas: 4

  • Nafria-Escalera B, Claverol J, Cubells M, Llanos C, Solé L, Sans E, López S, Català-Mora J, Rives-Solà S, Morales-La Madrid A, Pineda M, Garcia-Cazorla A, Nascimento-Osorio A, Morales-Ballús M, Roe D, Fortuny-Guasch C and Phillips B.

    Cross-border access to clinical trials: participation of pediatric patients and language inclusion

    PEDIATRIC RESEARCH . : .

    [doi:10.1038/s41390-026-04820-z]

  • Audhya I, Nacson AB, Gooch K, Basnyat B, Slota C, Martin S, Murphy A, Lansdall CJ, Ciobanu T, Nascimento-Osorio A and Veerapandiyan A.

    Caregiver-reported Patient Experiences with Duchenne Muscular Dystrophy: Qualitative In-trial Interviews 1 Year After Delandistrogene Moxeparvovec in the Pivotal EMBARK Trial

    Neurology and Therapy . 15(1): 41-60.

    [doi:10.1007/s40120-025-00842-7]